跳至主要内容
临床试验/DRKS00000010
DRKS00000010
已完成
不适用

Body compositional and endocrine-metabolic changes by long-term lifestyle intervention with health education, diet (Almased®), physical activity or a combination of diet and physical activity in obese persons

niversitätsklinikum Freiburg0 个研究点目标入组 114 人2008年9月5日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Dietoverweight
发起方
niversitätsklinikum Freiburg
入组人数
114
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2008年9月5日
结束日期
2002年12月1日
最后更新
去年
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • Eligible participants must have overweight with a BMI between 27,5 and 35 kg/m²
  • \- The participants must be able to participate in a physical activity program
  • \- The participants must be willing to participate in the program for 1 year
  • \- Written informed consent must be given to accept randomization to either of the intervention groups

排除标准

  • \- Participants who do not meet all entry criteria
  • \- BMI \> 35,0 kg / m²
  • \- Performance capacity \< 75 w for 2 min
  • \- Subjects younger than 35 yrs (with reference age at 1st Jan 2002: 34\.5 yrs) or older than 65 yrs (with reference age at 1st 2002: 65\.5 yrs)
  • \- Absolute or relative contraindications to exercise testing of the ACSM
  • \- Persons unable or with restrictions to participate in a regular physical activity program because of any disease (e.g. history of CHD, arrhythmia, valvular heart disease, arthritis of major joints)
  • \- Severe hypertension systolic BP of \> 200 mm Hg and or diastolic BP of \> 105 mm Hg at rest
  • \- Persons with established insulin dependent diabetes mellitus (IDDM)
  • \- Persons with a disease of the liver or the kidneys prohibiting high protein intake
  • \- Persons with a disease of the thyroid gland or taking thyroid hormones

结局指标

主要结局

未指定

相似试验

已完成
不适用
se of insulin sensitisers to revert metabolic syndrome
ISRCTN58810841Hospital Sant Joan de Deu (Spain)52
进行中(未招募)
1 期
Changes in weight, body composition and metabolic parameters in HIV infected patients after switch from 2- to 3-drug treatment
EUCTR2020-000205-89-DKDepartment of Infectious Diseases, Hvidovre Hospital126
进行中(未招募)
1 期
Changes in weight, body composition and metabolic parameters in HIV infected patients after switched treatment
EUCTR2019-004999-19-DKDepartment of infectious diseases, Hvidovre Hospital95
尚未招募
不适用
Changes in body composition, dietary intake, and physical activity in children with cancer - a master protocolGewichtsstoornissenbody compositionNutritional status1000301810027655
NL-OMON56855Prinses Máxima Centrum voor Kinderoncologie500
进行中(未招募)
不适用
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.
EUCTR2005-004163-39-ESHospital Sant Joan de Déu40